Quality-of-life assessment instruments used across ALS clinics

Area of Science:

• Neurology
• Palliative Care
• Health Services Research

Background:

• Quality of life (QoL) is crucial for amyotrophic lateral sclerosis (ALS) patients.
• Standardized QoL assessment tools exist but their clinical integration is uncertain.
• Understanding current QoL assessment practices and barriers is vital for improving patient care.

Purpose of the Study:

• To evaluate the current utilization of QoL assessment instruments in clinical settings for ALS patients.
• To identify barriers hindering the regular assessment of QoL in routine ALS care.
• To inform strategies for enhancing QoL monitoring in ALS management.

Main Methods:

• An anonymous survey was distributed to members of the Northeast ALS (NEALS) Consortium.
• Data from 73 respondents representing 148 clinics were analyzed using descriptive statistics.
• Clinic characteristics were compared using chi-square and Fisher exact tests.

Main Results:

• Approximately 49.3% of surveyed ALS clinics reported assessing QoL during patient visits.
• The most frequently used instruments were the ALS Assessment Questionnaire and the Amyotrophic Lateral Sclerosis Specific Quality of Life scale.
• Key barriers included uncertainty about which instrument to use and time constraints during clinic visits; QoL assessment correlated with palliative care access, not visit length.

Conclusions:

• QoL assessments are not universally implemented across all ALS centers.
• Despite limitations in generalizability due to low response rates, findings suggest a need for further investigation into the impact of QoL assessments on patient outcomes.
• Creative strategies, such as pre-visit patient self-assessments or telehealth, may increase the frequency of QoL assessments in ALS care.